U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

Among the companies with shares expected to actively trade in Friday's session are OmniVision Technologies Inc. (OVTI), Krispy Kreme Doughnuts Inc. (KKD) and Guess Inc. (GES).

OmniVision's fiscal fourth-quarter earnings surged as the chip maker's revenue jumped, though margins continued to contract. Shares soared 20% to $18.61 premarket as results topped the company's expectations and as it provided guidance for the current quarter above Walls Street estimates.

Krispy Kreme's fiscal first-quarter earnings jumped 33% as the doughnut chain's revenue and domestic same-store sales continued to improve. Shares climbed 10% to $15.70 premarket as results topped analyst expectations and as the company lifted its full-year earnings guidance.

Guess' fiscal first-quarter earnings fell 63% as the clothing company reported lower sales from its North American and European businesses. However, shares rose 6.6% to $31.29 premarket as per-share earnings beat the company's own expectations, and revenue fell in line.

Graphic Packaging Holding Co. (GPK) said certain of its stockholders are offering 15 million shares. The packaging company, which had around 347.5 million shares outstanding as of April 19, won't receive any proceeds from the offering. Shares were down 3.9% to $7.65 premarket.

Lions Gate Entertainment Corp. (LGF) swung to a fiscal fourth-quarter profit as the movie studio reported stronger revenue, while its bottom line was boosted by a large income-tax benefit. Shares rose 4.1% to $29.19 premarket as results sharply topped consensus estimates.

Palo Alto Networks Inc. (PANW) swung to a fiscal third-quarter loss as significantly higher operating expenses offset the Internet security company's improved revenue, and the latest period was further hurt by income-tax provisions. Shares slid 13% to $47.50 premarket as revenue fell short of analyst expectations.

Vanda Pharmaceuticals Inc. (VNDA) said it has submitted a new drug application to the U.S. Food and Drug Administration for tasimelteon, a circadian regulator. Shares rose 5.7% to $9.72 premarket.

 
   Watchlist: 
 

Celgene Corp. (CELG) said a European Medicines Agency committee has recommended approval of its oral anti-cancer therapy pomalidomide for patients with relapsed and refractory multiple myeloma.

CIT Group Inc. (CIT) will repurchase up to $200 million of stock following the Federal Reserve Bank of New York's move to lift restrictions it placed on the business lender during the financial crisis.

Copart Inc.'s (CPRT) fiscal third-quarter earnings fell 4% as the car auctioneer's increased expenses masked improved revenue.

Esterline Technologies Corp.'s (ESL) fiscal second-quarter earnings fell 21%--missing market expectations--as the specialty manufacturer posted lighter sales for avionics and controls, as well as sensors and systems.

Genesco Inc.'s (GCO) fiscal first-quarter earnings slipped 11% as the seller of hats and footwear reported weaker same-store sales amid a slow start to the period.

Pall Corp.'s (PLL) fiscal third-quarter earnings slid 7.4% as the manufacturer of filtration and purification products booked a loss from discontinued operations and as revenue in the industrial segment weakened.

Standard & Poor's Ratings Services raised its outlook on SanDisk Corp. (SNDK) to positive from stable, pointing to the flash memory-maker's good revenue growth prospects.

Splunk Inc.'s (SPLK) fiscal first-quarter loss narrowed as the data-analysis firm reported fewer charges, and revenue increased.

Write to Anna Prior at [e-mail]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires